Your trusted adviser for R&D Tax Credits, Creative Tax Relief, and R&D Grants
Your trusted adviser for R&D Tax Credits, Creative Tax Relief, and R&D Grants
Explore our news page for thought leadership articles, technical expertise and the latest developments in the world of innovation funding.
Filter
Myriad is excited to announce an essential win for the software development industry, in our recent battle with HMRC over an R&D tax credit claim dispute.
This article focuses on a critical avenue available to MedTech SMEs for driving growth - the strategic utilisation of Research and Development Tax Credits.
Hooke Biotechnology have secured €5.5m in blended finance from the highly competitive Horizon Europe EIC Accelerator to develop Mera.
The Grants team at Myriad Associates are proud to announce that they have secured over €30m from the Disruptive Technologies Innovation Fund (DTIF).
With a cool 70 robots now working within our healthcare sector, we take a closer look at what amazing technologies are on the way.
The Life Sciences sector covers everything from pharmaceuticals and disease research to plant life, biological resources and much more.
Onkimmune was founded in 2015 with the goal of developing novel anti-cancer therapies using Natural Killer (NK) cells.
Myriad Associates is proud to announce that 4 of our clients who applied for the Disruptive Technologies Innovation Fund were all approved on Monday 10th December.
hello@myriadassociates.com